FULL ALERT: Vivos Inc (RDGL) FDA approval of Cancer Treatment for Humans & Pets (IsoPet®)
Channel: RICH TV LIVE
Date: 02/10/2018

FULL ALERT: Vivos Inc (RDGL) FDA approval of Cancer Treatment for Humans & Pets (IsoPet®) - RICH TV LIVE - October 2, 2018 - Vivos Inc (OTC: RDGL) selected its first clinic for commercial sales of IsoPet

Vivos Inc., a pharmaceutical company in the process of researching and developing minimally invasive treatments to combat cancer in humans and animals, announced today that the Vista Veterinary Hospital in Kennewick WA, located near Vivos’ headquarters, has been selected for the commercial launch of IsoPet® therapy. After several meetings with the clinic’s veterinarian owners, a Memorandum of Understanding has been signed.

Vivos’ strategy is to partner with several regional clinics across the country using this pilot program to provide practical experience to be shared with other potential regional clinic partners. Having selected a local clinic as the pilot provider of IsoPet™ therapy will make for cost-effective frequent site visits for the assistance of facility set-up, certification training, and radioactive material handling licensing. Certification training and the process of acquiring a Radioactive Material License for the clinic from the Washington State Department of Health has begun.

It is expected that as the successful results of the therapies become known, pet owners from as far as Spokane, Seattle and Portland will seek to have their affected animals treated at the Vista Clinic. It is estimated that more than 9 million people live within 250 miles of Kennewick.

Dr. Mike Korenko, Vivos CEO stated “Best management practice dictates that we pilot partnering with a private clinic prior to expanding to other regional clinics across the county. We will gain practical experience, such as the effectiveness of our certification training and the time and effort required to obtain the Radioactive Material License. This will optimize the process of engaging with other treatment centers”.

As noted in a previous press release, the company will introduce IsoPet® to the larger veterinarian community at the annual Veterinary Cancer Society Conference to be held in Louisville, KY October 17-20, 2018. 
Subscribe - https://www.youtube.com/c/RICHTVLIVE
Visit - http://www.richtvlive.com/ a one-stop shop for cryptocurrency, stocks, sports, travel and trending topics. #richtvlive #stocks #news 

Join the Conversation get the RICH TV LIVE app at Google Play - https://play.google.com/store/apps/details?id=com.app.richtvlive
iPhone App Store - https://itunes.apple.com/us/app/richtvlive/id1212158240?Is=1&mt=8

Popular Uploads - https://goo.gl/tbvXGg
Most Recent Upload - https://goo.gl/unKXBy
YouTube Channel Page - https://goo.gl/yUdG7w
Subscribe - https://goo.gl/q2tLnn
Rich TV Live Playlist - https://goo.gl/e116JF
YouTube support Tubebuddy - https://www.tubebuddy.com/RICHTVLIVE

Disclaimer

Rich TV's company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in Rich TV reports company profiles or other investor relations materials and presentations are subject to change. Rich TV and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.

Investing is inherently risky. Rich TV is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.

We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov.